Cargando…
A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil
Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535927/ https://www.ncbi.nlm.nih.gov/pubmed/28677661 http://dx.doi.org/10.3390/ijms18071436 |
_version_ | 1783253926491979776 |
---|---|
author | Bombicz, Mariann Priksz, Daniel Varga, Balazs Kurucz, Andrea Kertész, Attila Takacs, Akos Posa, Aniko Kiss, Rita Szilvassy, Zoltan Juhasz, Bela |
author_facet | Bombicz, Mariann Priksz, Daniel Varga, Balazs Kurucz, Andrea Kertész, Attila Takacs, Akos Posa, Aniko Kiss, Rita Szilvassy, Zoltan Juhasz, Bela |
author_sort | Bombicz, Mariann |
collection | PubMed |
description | Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure, inhibiting angiotensin-converting enzyme (ACE), as well as improving right ventricle function in rabbit models with heart failure. We hypothesize that AU may mitigate cardiovascular damage caused by pulmonary arterial hypertension (PAH) and has value in the supplementary treatment of the complications of the disease. In this present investigation, PAH was induced by a single dose of monocrotaline (MCT) injection in Sprague-Dawley rats, and animals were divided into 4 treatment groups as follows: I. healthy control animals (Control group); II. pulmonary hypertensive rats (PAH group); III. pulmonary hypertensive rats + daily sildenafil treatment (Sildenafil group); and IV. pulmonary hypertensive rats + Wild garlic liophylisate-enriched chow (WGLL group), for 8 weeks. Echocardiographic measurements were obtained on the 0 and 8 weeks with fundamental and Doppler imaging. Isolated working heart method was used to determinate cardiac functions ex vivo after thoracotomy on the 8th week. Histological analyses were carried out on excised lung samples, and Western blot technique was used to determine Phosphodiesterase type 5 enzyme (PDE5) expression in both myocardial and pulmonary tissues. Our data demonstrate that right ventricle function measured by echocardiography was deteriorated in PAH animals compared to controls, which was counteracted by AU treatment. Isolated working heart measurements showed elevated aortic flow in WGLL group compared to PAH animals. Histological analysis revealed dramatic increase in medial wall thickness of pulmonary arteries harvested from PAH animals, but arteries of animals in sildenafil- and WGLL-treated groups showed physiological status. Our results suggest that bioactive compounds in Allium ursinum could have beneficial effects in pulmonary hypertension. |
format | Online Article Text |
id | pubmed-5535927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-55359272017-08-04 A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil Bombicz, Mariann Priksz, Daniel Varga, Balazs Kurucz, Andrea Kertész, Attila Takacs, Akos Posa, Aniko Kiss, Rita Szilvassy, Zoltan Juhasz, Bela Int J Mol Sci Article Right-sided heart failure—often caused by elevated pulmonary arterial pressure—is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure, inhibiting angiotensin-converting enzyme (ACE), as well as improving right ventricle function in rabbit models with heart failure. We hypothesize that AU may mitigate cardiovascular damage caused by pulmonary arterial hypertension (PAH) and has value in the supplementary treatment of the complications of the disease. In this present investigation, PAH was induced by a single dose of monocrotaline (MCT) injection in Sprague-Dawley rats, and animals were divided into 4 treatment groups as follows: I. healthy control animals (Control group); II. pulmonary hypertensive rats (PAH group); III. pulmonary hypertensive rats + daily sildenafil treatment (Sildenafil group); and IV. pulmonary hypertensive rats + Wild garlic liophylisate-enriched chow (WGLL group), for 8 weeks. Echocardiographic measurements were obtained on the 0 and 8 weeks with fundamental and Doppler imaging. Isolated working heart method was used to determinate cardiac functions ex vivo after thoracotomy on the 8th week. Histological analyses were carried out on excised lung samples, and Western blot technique was used to determine Phosphodiesterase type 5 enzyme (PDE5) expression in both myocardial and pulmonary tissues. Our data demonstrate that right ventricle function measured by echocardiography was deteriorated in PAH animals compared to controls, which was counteracted by AU treatment. Isolated working heart measurements showed elevated aortic flow in WGLL group compared to PAH animals. Histological analysis revealed dramatic increase in medial wall thickness of pulmonary arteries harvested from PAH animals, but arteries of animals in sildenafil- and WGLL-treated groups showed physiological status. Our results suggest that bioactive compounds in Allium ursinum could have beneficial effects in pulmonary hypertension. MDPI 2017-07-04 /pmc/articles/PMC5535927/ /pubmed/28677661 http://dx.doi.org/10.3390/ijms18071436 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bombicz, Mariann Priksz, Daniel Varga, Balazs Kurucz, Andrea Kertész, Attila Takacs, Akos Posa, Aniko Kiss, Rita Szilvassy, Zoltan Juhasz, Bela A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title | A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title_full | A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title_fullStr | A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title_full_unstemmed | A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title_short | A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil |
title_sort | novel therapeutic approach in the treatment of pulmonary arterial hypertension: allium ursinum liophylisate alleviates symptoms comparably to sildenafil |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535927/ https://www.ncbi.nlm.nih.gov/pubmed/28677661 http://dx.doi.org/10.3390/ijms18071436 |
work_keys_str_mv | AT bombiczmariann anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT prikszdaniel anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT vargabalazs anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kuruczandrea anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kerteszattila anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT takacsakos anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT posaaniko anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kissrita anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT szilvassyzoltan anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT juhaszbela anoveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT bombiczmariann noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT prikszdaniel noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT vargabalazs noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kuruczandrea noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kerteszattila noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT takacsakos noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT posaaniko noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT kissrita noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT szilvassyzoltan noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil AT juhaszbela noveltherapeuticapproachinthetreatmentofpulmonaryarterialhypertensionalliumursinumliophylisatealleviatessymptomscomparablytosildenafil |